A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Condition:   Transplanted Organ Rejection Intervention:   Biological: FCR001 Sponsor:   Talaris Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials